SEC Company Response from Item 9 Labs Corp. (INLB) (CIK 0001500123) — Feb 23, 2022
Item 9 Labs Corp. (INLB) (CIK 0001500123)
Date: Feb. 23, 2022 · CIK: 0001500123 · Accession: 0001554795-22-000067
AI Filing Summary & Sentiment
File numbers found in text: 024-11795
Letter
Re: Item 9 Labs Corp. (the “Company”)
February 23, 2022
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F. Street, N.E.
Washington, D.C. 20549
Attn: Jane Park , SEC Examiner
Offering Statement on Form 1-A (File No. 024-11795)
Qualification Request
Ladies and Gentlemen:
We respectfully request that the Company’s above-referenced Offering Statement be qualified by the Securities and Exchange Commission under Rule 252(e) of Regulation A promulgated under the Securities Act of 1933, as amended, at 2:00 PM (ET) on Friday, February 25, 2022, or as soon thereafter as is practicable.
Very truly yours,
Item 9 Labs Corp.
Show Raw Text
CORRESP 1 filename1.htm February 23, 2022 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F. Street, N.E. Washington, D.C. 20549 Attn: Jane Park , SEC Examiner Re: Item 9 Labs Corp. (the “Company”) Offering Statement on Form 1-A (File No. 024-11795) Qualification Request Ladies and Gentlemen: We respectfully request that the Company’s above-referenced Offering Statement be qualified by the Securities and Exchange Commission under Rule 252(e) of Regulation A promulgated under the Securities Act of 1933, as amended, at 2:00 PM (ET) on Friday, February 25, 2022, or as soon thereafter as is practicable. Very truly yours, Item 9 Labs Corp. By: /s/ Andrew Bowden Andrew Bowden Chief Executive Officer (Principal Executive Officer)